Cambridge Investment Research Advisors Inc. Has $413,000 Position in Waters Co. (NYSE:WAT)

Cambridge Investment Research Advisors Inc. trimmed its stake in shares of Waters Co. (NYSE:WAT) by 8.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,642 shares of the medical instruments supplier’s stock after selling 150 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Waters were worth $413,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of WAT. Norges Bank acquired a new stake in Waters during the fourth quarter worth about $130,150,000. Morgan Stanley grew its holdings in Waters by 188.1% during the third quarter. Morgan Stanley now owns 527,562 shares of the medical instruments supplier’s stock worth $102,707,000 after acquiring an additional 344,432 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd acquired a new stake in Waters during the first quarter worth about $70,947,000. Bristol John W & Co. Inc. NY acquired a new stake in Waters during the fourth quarter worth about $52,302,000. Finally, Massachusetts Financial Services Co. MA grew its holdings in Waters by 5.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,863,115 shares of the medical instruments supplier’s stock worth $917,426,000 after acquiring an additional 267,576 shares during the period. 92.63% of the stock is currently owned by hedge funds and other institutional investors.

Shares of WAT opened at $203.20 on Friday. The company has a current ratio of 3.44, a quick ratio of 2.89 and a debt-to-equity ratio of 1.15. Waters Co. has a 12 month low of $167.93 and a 12 month high of $255.21. The company has a market capitalization of $14.17 billion, a price-to-earnings ratio of 24.51, a price-to-earnings-growth ratio of 2.15 and a beta of 1.08.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, April 23rd. The medical instruments supplier reported $1.60 EPS for the quarter, missing the consensus estimate of $1.73 by ($0.13). Waters had a net margin of 24.59% and a return on equity of 39.64%. The business had revenue of $513.90 million during the quarter, compared to analyst estimates of $545.82 million. During the same period in the previous year, the business posted $1.59 earnings per share. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Research analysts anticipate that Waters Co. will post 9.11 earnings per share for the current year.

Several analysts recently commented on WAT shares. Zacks Investment Research lowered Waters from a “strong-buy” rating to a “hold” rating in a report on Friday, April 12th. ValuEngine lowered Waters from a “buy” rating to a “hold” rating in a report on Wednesday, April 24th. Barclays dropped their target price on Waters from $218.00 to $210.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 24th. Robert W. Baird dropped their target price on Waters from $211.00 to $209.00 and set a “neutral” rating on the stock in a report on Wednesday, April 24th. Finally, UBS Group dropped their price objective on Waters from $248.00 to $230.00 and set a “neutral” rating on the stock in a report on Wednesday, April 24th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. Waters has a consensus rating of “Hold” and a consensus price target of $208.71.

ILLEGAL ACTIVITY NOTICE: This article was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.baseballdailydigest.com/news/2019/06/16/cambridge-investment-research-advisors-inc-has-413000-position-in-waters-co-nysewat.html.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: Trading based on a resistance level

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.